Idexx Laboratories | IDXX - Selling And Administration Expenses


Idexx Laboratories reported $288.09M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Accuray USD 124.78M 2.54M Dec/2025
Align Technology USD 410.55M 52.12M Sep/2026
AngioDynamics USD 36.57M 3.79M Sep/2025
Dentsply International USD 364M 13M Jun/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
Fujifilm JPY 236.14B 20.3B Mar/2026
Globus Medical USD 286.82M 10.95M Jun/2026
Henry Schein USD 831M 22M Jun/2026
Idexx Laboratories USD 288.09M 11.76M Jun/2026
Inogen USD 43.77M 510K Jun/2024
Insulet USD 344.8M 27.6M Jun/2026
Integra LifeSciences USD 161.02M 5.2M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
Neogen USD 100.8M 1000K Jun/2026
Orthofix International USD 130.35M 11.31M Dec/2025
Phibro Animal Health USD 78.32M 10.24M Dec/2025
ResMed USD 290.65M 10.86M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Steris USD 369.7M 17.9M Jun/2026
Tandem Diabetes Care USD 111.64M 3.45M Jun/2026
Teleflex USD 213.52M 12.5M Jun/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Zoetis USD 592M 4M Jun/2026